UPDATED May 15, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
DPAM | €530.00 | -3.6% | 6.9% | €51.8m | n/a | PE12.1x | n/a | 7.7% | ||
TTE | €67.47 | 0.4% | 22.3% | €156.1b | €73.18 | PE7.9x | E-3.1% | 4.6% | ||
TE | €23.26 | 1.0% | 18.2% | €4.1b | €26.25 | PE13.5x | E13.0% | 2.5% | ||
ES | €181.80 | 3.6% | 320.8% | €2.3b | n/a | PE3.5x | n/a | 1.7% | ||
VK | €16.74 | 2.4% | 48.0% | €3.8b | €20.83 | PE7.8x | E10.1% | 0% | ||
GTT | €135.50 | 1.0% | 41.5% | €5.0b | €164.60 | PE24.9x | E10.3% | 3.7% | ||
EC | €174.50 | 0.6% | -4.2% | €785.3m | n/a | PE32.4x | n/a | 11.7% | ||
MAU | €6.44 | 0.9% | 85.3% | €1.3b | €5.90 | PE6.6x | E12.9% | 3.5% | ||
LHYFE | €4.31 | -2.2% | -38.9% | €206.1m | €5.53 | PS156.5x | E11.1% | n/a | ||
ALEO2 | €5.14 | 6.2% | -6.2% | €13.0m | n/a | PE2.8x | n/a | n/a | ||
FDE | €37.80 | 9.6% | -3.0% | €197.7m | €64.07 | PE25.1x | E37.6% | n/a | ||
MLSEQ | €0.011 | 0% | -21.4% | €10.5m | n/a | PB1x | n/a | n/a |